Pulling SEC filings + quote and writing the call…

RCM TECHNOLOGIES, INC.
Next earnings Aug 4, 2026 · consensus $0.63 EPS, $83.4M rev
Last earnings +32.0% on 2026-04-03
Cheap, cash-generative staffing/solutions compounder: 13x earnings for 27% EPS growth, 35% ROE, and a shrinking share count.
Diluted EPS $2.14 · FY2026
Quality fundamentals and an attractive price line up (~185% below fair value) — the rarer case where both the business and the entry look good.
RCMT is a small-cap business-and-technology solutions/staffing firm that has quietly turned into a profitable compounder. Revenue has grown every year of the record shown — $150M → $204M → $263M → $278M → $319M — and FY2026's $319M is up 14.7% YoY. Crucially, growth is falling through to owners: net income rose 22.6% to $16.3M, operating cash flow tripled (+207%) to $19.0M against just $1.59M of capex, and diluted EPS jumped 27.4% to $2.14 — faster than net income because management retired 7.4% of the share count with $7.36M of buybacks. That capital-return discipline, plus a 35.5% ROE and retained earnings swinging up 275% to $10.4M, is exactly what you want in a low-margin services business.
Valuation does not reward any of this. At $28.50 the stock trades at 13.3x FY EPS and 0.6x sales — a sub-1 PEG on ~27% EPS growth. For a company throwing off cash, buying back stock, and growing double digits, that is a demanding-of-nothing multiple. Balance-sheet leverage looks optically high (liabilities/equity 1.92x), but liabilities actually fell 10.3% while equity grew 37.3%, and the debt is a variable-rate revolver where a 100bp rate move only shifts interest expense ~$0.4M — immaterial against $25.1M of operating income. The real balance-sheet caveat is thin cash of $2.92M (down 38%), which leaves little cushion and makes the company reliant on its credit line for working-capital swings.
Is RCMT a buy? The one-page verdict, explained →
High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Revenue | $150M | $204M | $263M | $278M | $319M |
| Gross profit | $38.9M | $53.1M | $76.7M | $79.8M | $87.9M |
| Operating income | -$10.9M | $14.1M | $23.7M | $22.3M | $25.1M |
| Net income | -$8.87M | $11.0M | $16.8M | $13.3M | $16.3M |
| Diluted EPS | -$0.73 | $0.95 | $1.96 | $1.68 | $2.14 |
| Net margin | -5.9% | 5.4% | 6.4% | 4.8% | 5.1% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1 FY2027 report (period ended 2026-04-04) — quarterly results update
10-K/A amends FY2026 annual report (Part III/auditor-related items)
10-K/A amends FY2026 annual report (Part III/auditor-related items)
FY2026 10-K: rev +14.7% to $319M, net income +22.6%, EPS +27.4%, ROE 35%
FY2026 10-K: rev +14.7% to $319M, net income +22.6%, EPS +27.4%, ROE 35%
NT 10-K: notified SEC it would file FY2026 annual report late
Items 1.01/2.03: new/amended revolving credit facility, added debt obligation
Items 5.02/5.07: annual-meeting vote results and director/officer changes
DEF 14A proxy for annual meeting — board, comp and auditor ratification
Sources: SEC EDGAR (CIK 0000700841, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/3/2026, 3:28:24 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 11:28 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 13 sales
| 2026-05-04 | Saks Michael Division President, HC Srvs. | Sell | 1.21K @ $32.50 | $39.3K |
| 2026-05-04 | MILLER KEVIN D CFO | Sell | 19.1K @ $32.03 | $611K |
| 2026-04-27 | MILLER KEVIN D CFO | Sell | 4.73K @ $32.00 | $151K |
| 2026-04-24 | MILLER KEVIN D CFO | Sell | 2.93K @ $32.04 | $93.9K |
| 2026-04-22 | MILLER KEVIN D CFO | Sell | 1.48K @ $32.00 | $47.5K |
| 2026-04-20 | MILLER KEVIN D CFO | Sell | 2.38K @ $32.02 | $76.4K |
| 2026-04-17 | MILLER KEVIN D CFO | Sell | 3.00K @ $32.00 | $96.0K |
| 2026-04-16 | Saks Michael Division President, HC Srvs. | Sell | 4.86K @ $30.00 | $146K |
| 2026-04-16 | Vizi Bradley Executive Chairman & President | Sell | 49.9K @ $30.00 | $1.50M |
| 2026-04-15 | Saks Michael Division President, HC Srvs. | Sell | 136.00 @ $30.00 | $4.08K |
| 2026-04-15 | Vizi Bradley Executive Chairman & President | Sell | 140.00 @ $30.00 | $4.20K |
| 2026-04-08 | Vizi Bradley Executive Chairman & President | Sell | 8.24K @ $27.52 | $227K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median